A 1-Year Safety Study of Duloxetine in Patients With Fibromyalgia Syndrome
A 1-Year Safety Study of Duloxetine in Patients With Fibromyalgia Syndrome
This study is designed to evaluate duloxetine for the treatment of fibromyalgia syndrome patients.
Inclusion Criteria:
Exclusion Criteria:
Buenos Aires, Argentina
Capital Federal, Argentina
Cotton Tree, Queensland 4558, Australia
Malvern, Victoria 3144, Australia
Hobart, Australia
Melbourne, Australia
Curitiba, 80060-240, Brazil
Goiânia, 74043-110, Brazil
Recife, 52020-010, Brazil
Rio de Janeiro, 20551-030, Brazil
São Paulo, Brazil
St. John's, Newfoundland and Labrador A1C 2H5, Canada
London, Ontario N6A 4V2, Canada
Toronto, Ontario M5T 3A9, Canada
Saskatoon, Saskatchewan S7K 0H6, Canada
Morelia, Michoacán, Mexico
Mérida, Yucatán, Mexico
Guadalajara, Mexico
Mexico City, Mexico
Lublin, Poland
Poznan, Poland
Szczecin, Poland
Wroclaw, Poland
Kaohsiung City, Taiwan
Taichung, Taiwan
Taipei, Taiwan